For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

DIABETES, Parkinson's disease, degenerative disc disease, macular degeneration, stroke — what do these have in common?

PHILADELPHIA - Century Therapeutics, Inc. (NASDAQ: IPSC), a biotechnology firm with a market capitalization of $77.32 million ...

A WOMAN from Salisbury had her head shaved to raise money for charity after being diagnosed with MS. Hannah Schmidt, 35, is a mum of three boys and the family lives in Salisbury. In December 2020, she ...

Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.

Recent important developments presented at the European Congress for Treatment and Research in Multiple Sclerosis and other meetings were also considered.

Additionally, Arvinas has initiated a Phase 1 trial of the PROTAC LRRK2 degrader ARV-102 for Parkinson's disease and expects to present data from multiple ... patients with B-cell lymphomas.” ...

The company expects the last relapsing-remitting multiple sclerosis patient to complete the trial by the third quarter of this year. Credit: illustrissima ...

The Abu Dhabi Stem Cells Center (ADSCC ... diseases such as Alzheimer's, multiple sclerosis, Parkinson's, and diabetes. To treat these conditions, ADSCC is actively conducting multiple research ...